PI3K/AKT/mTOR通路
乳腺癌
癌症研究
医学
蛋白激酶B
癌症
ErbB公司
肿瘤进展
细胞凋亡
内科学
生物
遗传学
作者
Jiao-Qun Zhou,Shiwei Zhang,Mingyuan Luo
出处
期刊:Future Oncology
[Future Medicine]
日期:2021-02-01
卷期号:17 (6): 701-710
被引量:4
标识
DOI:10.2217/fon-2020-0273
摘要
Aim: This study aimed to explore the mechanism of lncRNA PCAT7 underlying the progression of breast cancer, which will provide a basis for accurate diagnosis and targeted treatment. Methods: Data from The Cancer Genome Atlas data associated with breast cancer were used to identify the target lncRNA. In vitro experiments were conducted to detect gene expression and the effect of the lncRNA on cancer cell activities. Results: PCAT7 was found to be highly expressed in breast cancer tissue and cells, which activated the ErbB/PI3K/Akt pathway to potentiate cancer cell proliferation, migration and invasion and suppress apoptosis. Conclusion: PCAT7 is likely to promote tumor cell activities by activating ErbB/PI3K/Akt pathway, in turn potentiating tumor malignant progression.
科研通智能强力驱动
Strongly Powered by AbleSci AI